Language
English
We offer our registered users tailored information, free online courses and exclusive content.
Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?
... or you lost your password?English
Meridiano Congress International
Senior Event Manager: Titty Alvino
T +39 06 88 595 310 - F +39 06 88595 234
titty.alvino@meridiano.it
For logistical inquiries as well.
• Scientific sessions
• Coffee breaks and luncheons
• Educational materials
• Certificate of attendance
Dinners are not included.
Diabetes and thyroid disorders are two of the most prevalent non-communicable chronic diseases worldwide, both having a heavy impact on patients’ quality of life and life expectancy. The number of people affected by diabetes mellitus is close to half a billion and the rising trend in diabetes prevalence worldwide is far from slowing, with catastrophic outcomes in terms of morbidity, mortality and healthcare expenditures. Type 2 diabetes, characterized by a systemic resistance to insulin action, is the most common form of diabetes mellitus. While efforts should be made to prevent overt diabetes, when this is not possible, a deep knowledge of the most up-to-date treatment strategies is crucial to ensuring a longer life expectancy and good quality of life for diabetic patients. Disorders in thyroid function are also very common and can lead to severe consequences if not promptly recognized and treated. Thyroid receptors have been found on several cell types, suggesting that thyroid hormones are involved in the regulation of the homeostasis of several tissues and organs. In particular, several studies have now clarified the relevant action of thyroid hormones on endothelial cells and cardiomyocytes. Indeed, even subclinical thyroid disorders are associated with adverse cardiovascular outcomes. In addition, thyroid nodules affect more than 50 percent of the general population, challenging the clinicians in daily clinical practice. This live educational programme has been organized by EXCEMED to review the most recent and significant research advances in the fields of pre-diabetes, diabetes and thyroid diseases, with the goal of having immediate clinical impact.
By attending this conference, participants will be able to:
08.20 Welcome & opening
08.30 L1 Insulin resistance beyond glycaemia
M.L. Morieri (USA)
Discussion
09:05 L2 Focus on pre-diabetes Watch the expert interview
P. Pozzilli (Italy)
Discussion
09.40 L3 Cardiovascular effects of antidiabetic drugs
D. Leslie (UK)
Discussion
10.15 Roundtable: The insulin resistant pregnant woman: what consequences for the off-spring?
P. Pozzilli (Italy), M.L. Morieri (USA), D. Leslie (UK)
Question time
10.50 coffee break
11.05 L4 Thyroid hormones and the cardiovascular system
S. Razvi (UK)
Discussion
11.40 L5 Thyroid and pregnancy
T. Korevaar (The Netherlands)
Discussion
12.15 Working groups: clinical case solving
13.15 Working groups: outcome presentation in plenary
14:00 KNL The changing face of diabetes
R. DeFronzo (USA)
14.35 Concluding remarks
End of the conference
Closing lunch
Programme Manager: Michela Fiuzzi
T +39 06 420413 252 - F +39 06 420413 677
michela.fiuzzi@excemed.org
Medical Advisor: Ernesto Maddaloni
e.maddaloni@unicampus.it